Morgan Stanley’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Morgan Stanley’s Portfolio CPHR Stock Details CPHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-13,200	Closed	-$50K	–	6648
2016 Q3	$50K	Sell	13,200 -13,300	-50%	-$60.6K	﹤0.01%	5598
2016 Q2	$138K	Buy	26,500 +17,620	+198%	+$100K	﹤0.01%	5101
2016 Q1	$42K	Sell	8,880 -29,035	-77%	-$127K	﹤0.01%	5686
2015 Q4	$178K	Sell	37,915 -89,129	-70%	-$386K	﹤0.01%	5147
2015 Q3	$471K	Buy	127,044 +16,544	+15%	+$115K	﹤0.01%	4656
2015 Q2	$946K	Sell	110,500 -51,450	-32%	-$513K	﹤0.01%	4245
2015 Q1	$1.47M	Buy	161,950 +45,694	+39%	+$574K	﹤0.01%	3841
2014 Q4	$1.65M	Buy	+116,256	New	+$1.69M	﹤0.01%	3728

Other funds holding CPHR

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

NEI

Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Morgan Stanley's CPHR Position: Q4 2016 in Review

Morgan Stanley sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q4 2016, closing a stake of 13,200 shares — an estimated $50K sold.

Morgan Stanley first reported a position in CPHR in Q4 2014 and held it in 8 quarters. The position peaked at $1.65M in Q4 2014. 3 funds tracked by Wall St. Rank hold CPHR as of Q4 2016.

Morgan Stanley reported no remaining Cipher Pharmaceuticals Inc. position as of Q4 2016 after selling out during the quarter.
Morgan Stanley sold 13,200 Cipher Pharmaceuticals Inc. shares in Q4 2016, an estimated $50K.
Morgan Stanley first reported a position in Cipher Pharmaceuticals Inc. in Q4 2014 and held it in 8 quarters.
Morgan Stanley's Cipher Pharmaceuticals Inc. position peaked at $1.65M in Q4 2014.
3 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q4 2016.

Based on Morgan Stanley's 13F filing for Q4 2016, filed 13 Feb 2017.